According to the latest report from India's "companies and markets" network, the Indian biotechnology market in 2017 will be expected to exceed 11 billion U.S. dollars. The increase in overseas investment, R&D, and infrastructure investment, the increase in the R&D market for new contracts, R&D of new drugs, and outsourced processing are the main reasons driving this growth.

The Indian biotechnology market accounts for about 2% of the global biotechnology market, with the top 12 biotech companies in the world. India’s biotechnology market ranks third in Asia, behind Japan and South Korea.

The export of biotechnology industry still accounts for the largest share of India's biotechnology industry's fiscal revenue, which also makes Indian biotechnology companies continue to receive attention in the international market. The main areas involved in the export industry are biopharmaceuticals, bioinformatics, and bioservices. Bio-industry and bio-agriculture, on the other hand, mainly occupy the Indian domestic market share.

The income of the biotechnology industry in the West India region tops the list, but South India regions such as Bangalore and Hyderabad also have biotechnology centers where there are numerous biotechnology companies. According to statistics, as many as 172 biotechnology companies were located in southern India in 2010.

In India, there are more than 350 companies involved in biotechnology. Top of the list are Biocon, Indian Serum Institute and Panacea Biotech.